Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Atossa Therapeutics Inc. (ATOS) Insider Trading Activity
Healthcare • Biotechnology • 12 employees
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.
Total Value
$7,000.00
Total Shares
10,000
Average Trade Value
$7,000.00
Most Active Insider
Remmel H. Lawrence
Total Activity: $7,000
Largest Single Transaction
$7,000
by Remmel H. Lawrence on Mar 26, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
| Mar 26, 2025 | 10,000 | $7,000 | 10,257 (+97.5%) | Purchase |